Healthpeak Properties (NYSE:DOC) Earns “Outperform” Rating from Wedbush

Healthpeak Properties (NYSE:DOC)‘s stock had its “outperform” rating restated by stock analysts at Wedbush in a report issued on Friday,Benzinga reports. They presently have a $24.00 price objective on the real estate investment trust’s stock. Wedbush’s price objective indicates a potential upside of 32.30% from the stock’s previous close. Wedbush also issued estimates for Healthpeak Properties’ Q3 2025 earnings at $0.46 EPS, Q4 2025 earnings at $0.47 EPS, Q1 2026 earnings at $0.48 EPS, Q2 2026 earnings at $0.49 EPS, Q3 2026 earnings at $0.49 EPS and Q4 2026 earnings at $0.50 EPS.

Other equities research analysts have also recently issued reports about the stock. Scotiabank decreased their price objective on shares of Healthpeak Properties from $24.00 to $23.00 and set a “sector outperform” rating for the company in a research report on Friday, February 28th. Morgan Stanley upgraded Healthpeak Properties from an “equal weight” rating to an “overweight” rating and set a $25.00 price target for the company in a report on Wednesday, January 15th. StockNews.com raised Healthpeak Properties from a “sell” rating to a “hold” rating in a research report on Saturday, March 22nd. Finally, Robert W. Baird cut their target price on Healthpeak Properties from $25.00 to $24.00 and set an “outperform” rating on the stock in a research report on Tuesday, February 11th. Four research analysts have rated the stock with a hold rating, nine have issued a buy rating and one has assigned a strong buy rating to the company. According to MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus target price of $23.83.

Healthpeak Properties Stock Performance

Shares of DOC stock opened at $18.14 on Friday. The stock has a market capitalization of $12.69 billion, a PE ratio of 51.83, a PEG ratio of 2.17 and a beta of 1.02. The business’s 50 day simple moving average is $19.79 and its 200 day simple moving average is $20.82. The company has a debt-to-equity ratio of 0.96, a current ratio of 1.35 and a quick ratio of 1.35. Healthpeak Properties has a one year low of $17.33 and a one year high of $23.26.

Institutional Trading of Healthpeak Properties

Hedge funds have recently bought and sold shares of the business. Parallel Advisors LLC grew its holdings in shares of Healthpeak Properties by 4.2% during the first quarter. Parallel Advisors LLC now owns 13,980 shares of the real estate investment trust’s stock valued at $283,000 after buying an additional 561 shares during the last quarter. AdvisorNet Financial Inc boosted its stake in Healthpeak Properties by 34.5% during the 4th quarter. AdvisorNet Financial Inc now owns 2,193 shares of the real estate investment trust’s stock valued at $44,000 after purchasing an additional 563 shares during the last quarter. Townsquare Capital LLC increased its holdings in Healthpeak Properties by 5.9% during the 4th quarter. Townsquare Capital LLC now owns 10,461 shares of the real estate investment trust’s stock worth $212,000 after purchasing an additional 584 shares in the last quarter. Exchange Traded Concepts LLC raised its stake in shares of Healthpeak Properties by 10.0% in the fourth quarter. Exchange Traded Concepts LLC now owns 6,560 shares of the real estate investment trust’s stock worth $133,000 after purchasing an additional 598 shares during the last quarter. Finally, Huntington National Bank lifted its holdings in shares of Healthpeak Properties by 3.0% in the fourth quarter. Huntington National Bank now owns 20,843 shares of the real estate investment trust’s stock valued at $422,000 after purchasing an additional 613 shares in the last quarter. Institutional investors and hedge funds own 93.57% of the company’s stock.

Healthpeak Properties Company Profile

Healthpeak Properties, Inc is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.